During the past decade, Penn State Health Saint Joseph Medical Center conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 38 clinical trials were completed, i.e. on average, 131% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 26 clinical trials were completed. i.e. 866.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Penn State Health Saint Joseph Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 22 trials, followed by "SWOG Cancer Research Network" with 11 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored and "Abbott Medical Devices" with 5 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Penn State Health Saint Joseph Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 37 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator and "North Central Cancer Treatment Group" with 5 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Penn State Health Saint Joseph Medical Center" are "Breast Cancer" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "Recurrent Breast Carcinoma" (5 trials) and "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (5 trials). Many other conditions were trialed in "Penn State Health Saint Joseph Medical Center" in a lesser frequency.

Most popular intervention types in "Penn State Health Saint Joseph Medical Center" are "Drug" (51 trials), "Other" (39 trials), "Biological" (22 trials), "Radiation" (13 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (28 trials), "Paclitaxel" (10 trials), "Docetaxel" (9 trials), "Quality-of-Life Assessment" (9 trials) and "Carboplatin" (7 trials). Other intervention names were less common.

The vast majority of trials in "Penn State Health Saint Joseph Medical Center" are 51 trials for "All" genders, 11 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Penn State Health Saint Joseph Medical Center". undefined are not yet recruiting, 8 are recruiting, 27 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Penn State Health Saint Joseph Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Penn State Health Saint Joseph Medical Center, 2 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".